Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 The Claret Montage Filter Device: Technology and Early Clinical Experiences Presenter: Eberhard Grube June 12, 2013
Presentation TVT 2013 The Keystone Deflector Device: Technology and Early Clinical Experiences Presenter: Jeffrey Moses June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Apica TA-TAVR System Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 Frailty Predictors of Clinical Outcomes in TAVR Patients: Early Insights Presenter: Philip Green June 12, 2013